Herbs or medicinal plants have a long history in treating disease and health disorders. In traditional Chinese medicine, for example,
written history of herbal medicine goes back over 2000 years and herbalists in
West have used “weeds” equally long to treat that which ails us. We are all familiar with
virtues of Garlic, Chamomile, Peppermint, Lavender, and other common herbs.Interest in medicinal herbs is on
rise again and
interest is primarily from
pharmaceutical industry, which is always looking for ‘new drugs’ and more effective substances to treat diseases, for which there may be no or very few drugs available.
Considering
very long traditional use of herbal medicines and
large body of evidence of their effectiveness, why is it that we are not generally encouraged to use traditional herbal medicine, instead of synthetic, incomplete copies of herbs, called drugs, considering
millions of dollars being spent looking for these seemingly elusive substances?
Herbs are considered treasures when it comes to ancient cultures and herbalists, and many so-called weeds are worth their weight in gold. Dandelion, Comfrey, Digitalis (Foxglove),
Poppy, Milk Thistle, Stinging nettle, and many others, have well-researched and established medicinal qualities that have few if any rivals in
pharmaceutical industry. Many of them in fact, form
bases of pharmaceutical drugs.
Research into
medicinal properties of such herbs as
humble Dandelion is currently being undertaken by scientists at
Royal Botanical Gardens, in Kew, west London, believe it could be
source of a life-saving drug for cancer patients.
Early tests suggest that it could hold
key to warding off cancer, which kills tens of thousands of people every year.
Their work on
cancer-beating properties of
dandelion, which also has a history of being used to treat warts, is part of a much larger project to examine
natural medicinal properties of scores of British plants and flowers.
Professor Monique Simmonds, head of
Sustainable Uses of Plants Group at Kew, said: "We aren't randomly screening plants for their potential medicinal properties, we are looking at plants which we know have a long history of being used to treat certain medical problems.”
“We will be examining them to find out what active compounds they contain which can treat
illness.”
Unfortunately, as is so often
case, this group of scientists appears to be looking for active ingredients, which can later be synthesized and then made into pharmaceutical drugs. This is not
way herbs are used traditionally and their functions inevitably change when
active ingredients are used in isolation. That’s like saying that
only important part of a car is
engine – nothing else needs to be included…
So, why is there this need for isolating
‘active ingredients’?
As a scientist, I can understand
need for
scientific process of establishing
fact that a particular herb works on a particular disease, pathogen or what ever, and
need to know why and how it does so. But, and this is a BIG but, as a doctor of Chinese medicine I also understand
process of choosing and prescribing COMBINATIONS of herbs, which have a synergistic effect to treat not just
disease, but any underlying condition as well as
person with
disease – That is a big difference and not one that is easily tested using standard scientific methodologies.
Using anecdotal evidence, which after all has a history of thousands of years, seems to escape my esteemed colleagues all together. Rather than trying to isolate
active ingredient(s), why not test these herbs, utilizing
knowledge of professional herbalists, on patients in vivo, using
myriad of technology available to researchers and medical diagnosticians to see how and why these herbs work in living, breathing patients, rather than in a test tube or on laboratory rats and mice (which, by
way, are not humans and have a different, although some what similar, physiology to us…).
I suspect, that among
reasons for not following
above procedure is that
pharmaceutical companies are not really interested in
effects of
medicinal plants as a whole, but rather in whether they can isolate a therapeutic substance which can then be manufactured cheaply and marketed as a new drug - and of course that’s where
money is…